BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20144748)

  • 21. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
    Sonaje K; Lin KJ; Wey SP; Lin CK; Yeh TH; Nguyen HN; Hsu CW; Yen TC; Juang JH; Sung HW
    Biomaterials; 2010 Sep; 31(26):6849-58. PubMed ID: 20619787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of quaternized polydimethylaminoethylmethacrylate sub-microparticles for oral insulin delivery.
    Sonia TA; Sharma CP
    J Biomater Appl; 2013 Jul; 28(1):62-73. PubMed ID: 22718950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
    Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
    Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
    Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of thiolated polydimethylaminoethylmethacrylate hydrogel sub-microparticles for oral insulin delivery.
    Sonia TA; Sharma CP
    J Biomed Nanotechnol; 2013 Apr; 9(4):590-600. PubMed ID: 23621017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular evaluation of oral chemotherapy carriers.
    Blanchette J; Peppas NA
    J Biomed Mater Res A; 2005 Mar; 72(4):381-8. PubMed ID: 15666363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly methacrylic acid-alginate semi-IPN microparticles for oral delivery of insulin: a preliminary investigation.
    Sajeesh S; Sharma CP
    J Biomater Appl; 2004 Jul; 19(1):35-45. PubMed ID: 15245642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
    Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles.
    Ahmad N; Mohd Amin MC; Ismail I; Buang F
    Expert Opin Drug Deliv; 2016; 13(5):621-32. PubMed ID: 26943455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
    Sonaje K; Lin YH; Juang JH; Wey SP; Chen CT; Sung HW
    Biomaterials; 2009 Apr; 30(12):2329-39. PubMed ID: 19176244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
    Kavimandan NJ; Losi E; Peppas NA
    Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
    Kim BY; Jeong JH; Park K; Kim JD
    J Control Release; 2005 Feb; 102(3):525-38. PubMed ID: 15681076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro cell culture evaluation and in vivo efficacy of amphiphilic chitosan for oral insulin delivery.
    Shelma R; Sharma CP
    J Biomed Nanotechnol; 2013 Feb; 9(2):167-76. PubMed ID: 23627043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of pH-sensitive anionic hydrogel microparticles for oral protein-delivery applications.
    Kim B; Lim SH; Ryoo W
    J Biomater Sci Polym Ed; 2009; 20(4):427-36. PubMed ID: 19228445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.
    Huynh DP; Im GJ; Chae SY; Lee KC; Lee DS
    J Control Release; 2009 Jul; 137(1):20-4. PubMed ID: 19285530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.